FIRST SUPPLEMENTAL INDENTURE Supplementing the Indenture dated as of February 16, 2018 AVADEL FINANCE CAYMAN LIMITED, as Notes Issuer and AVADEL PHARMACEUTICALS PLC, as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee Dated as of February 6, 2019First Supplemental Indenture • February 7th, 2019 • Avadel Pharmaceuticals PLC • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of February 6, 2019 (this “First Supplemental Indenture”), by and among Avadel Finance Cayman Limited, a Cayman Islands exempted company limited by its shares (the “Company”), Avadel Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland (“Avadel”), and The Bank of New York Mellon, a New York banking corporation (the “Trustee”), as Trustee under the Indenture dated as of February 16, 2018 by and among the Company, Avadel and the Trustee (the “Indenture”). Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Indenture.
